Zimmer Biomet Holdings (ZBH) Depreciation & Amortization (CF) (2009 - 2026)
Zimmer Biomet Holdings (ZBH) posted Depreciation & Amortization (CF) of $270.8 million for Q2 2026, little changed on a QoQ basis from $270.0 million in Q1 2026, and little changed year-over-year from $271.8 million in Q2 2025.
Analysis
Zimmer Biomet Holdings (ZBH) Depreciation & Amortization (CF) (2009 - 2026) Analysis & Trends
Zimmer Biomet Holdings has reported Depreciation & Amortization (CF) for 18 years, with the latest figure at $270.8 million in Q2 2026.
- On a quarterly basis, Depreciation & Amortization (CF) changed 0.37% year-over-year to $270.8 million in Q2 2026; TTM through Jun 2026 was $1.1 billion, a 6.51% increase from a year earlier, with the FY2025 full-year figure at $1.1 billion, up 9.79% from the prior year.
- Depreciation & Amortization (CF) was $270.8 million for Q2 2026 at Zimmer Biomet Holdings, roughly flat from $270.0 million in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $284.0 million in Q4 2025, with the low at $228.5 million in Q4 2022.
- Average Depreciation & Amortization (CF) over 5 years is $250.5 million, with a median of $242.2 million recorded in 2023.
- The sharpest annual moves came in 2022 and 2025: Depreciation & Amortization (CF) decreased 2.02% in 2022, then climbed 13.03% in 2025.
- Over 5 years, Depreciation & Amortization (CF) stood at $228.5 million in 2022, then increased by 5.56% to $241.2 million in 2023, then grew by 9.29% to $263.6 million in 2024, then gained by 7.74% to $284.0 million in 2025, then dropped by 4.65% to $270.8 million in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $270.8 million (Q2 2026), $270.0 million (Q1 2026), and $284.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 192.30 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 729.00 Mn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 355.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 42.70 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 68.20 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 123.80 Mn |
| 10 | Zimmer Biomet Holdings | 18.20 Bn | 17.79 Bn | 1.54 Bn | 270.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 270.80 Mn |
| Mar 31, 2026 | 270.00 Mn |
| Dec 31, 2025 | 284.00 Mn |
| Sep 30, 2025 | 283.60 Mn |
| Jun 30, 2025 | 271.80 Mn |
| Mar 31, 2025 | 254.40 Mn |
| Dec 31, 2024 | 263.60 Mn |
| Sep 30, 2024 | 250.90 Mn |
| Jun 30, 2024 | 243.20 Mn |
| Mar 31, 2024 | 238.60 Mn |
| Dec 31, 2023 | 241.20 Mn |
| Sep 30, 2023 | 241.20 Mn |
| Jun 30, 2023 | 237.50 Mn |
| Mar 31, 2023 | 231.80 Mn |
| Dec 31, 2022 | 228.50 Mn |
| Sep 30, 2022 | 231.40 Mn |
| Jun 30, 2022 | 232.70 Mn |
| Mar 31, 2022 | 233.80 Mn |
| Dec 31, 2021 | 233.20 Mn |
| Sep 30, 2021 | 233.00 Mn |